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Abstract
Satb1 is a first cell-type-specific transcription factor of a novel type that functions as a regulator of the transcription of large chromatin
domains. We identified a close homologue of Satb1, Satb2, in a cDNA subtraction screening in a search for genes controlling neural
differentiation. Satb2 showed 61% amino-acid homology to Satb1. Satb2 and Satb1 expression was detected in different cell
subpopulations of developing mouse CNS in a mutually exclusive manner. In the electrophoretic mobility shift assay we demonstrate
that nuclear extracts from the embryonic day 18.5 mouse developing neocortex, in contrast to basal ganglia, contain a protein
complex interacting with matrix attachment region DNA elements (MARs) with high affinity. Endogenous Satb2 protein is a part of this
complex. In the developing neocortex Satb2 was detected largely in the superficial layers. In the developing spinal cord Satb2
expression marks a subpopulation of Lbx1-positive neurons dorsally and a subgroup of Isl1-positive neurons ventrally. In the Lbx1
mutants Satb2 expression is greatly reduced. We suggest that Satb2 may regulate differentiation of subsets of neurons at the level of
higher order chromatin structure via binding to MARs.
Introduction
The tissue-specific regulation of gene expression is critical to the
development and function of all higher eukaryotic organisms. Tissue-
specific transcription is controlled by the presence of certain sets of
transcription factors that activate or suppress the expression of a subset
of genes in a given cell type. In addition, chromatin modification is
involved in the regulation of gene activity (Fry & Peterson, 2001).
Recent studies suggest the importance of high-order chromatin
structure in the regulation of gene expression (Schubeler et al.,
2000). Cell-type-specific gene regulation, at the level of chromatin
organization, is an important aspect of cellular differentiation.
However, this remains poorly studied.
Recently, the first transcription factor of a novel type that seems to be
involved in the regulation of tissue-specific organization of chromatin,
Satb1, was identified. Satb1 is a nuclear protein that can bind to a core
unwinding element within the matrix attachment DNA region (MAR)
(Dickinson et al., 1992). Unlike classic transcription factors, which
bind individual target genes to regulate transcription, Satb1, which
binds to multiple sites where chromatin is fastened to form loop
domains, may dictate the organization and structure of chromatin
domains, thereby orchestrating the transcription potential of multiple
genes. Satb1 ablation led to gene disregulation affecting multiple genes
in T-cells (Alvarez et al., 2000). Gene knock-out studies have also
demonstrated that Satb1 acts as a global regulator of thymocyte
differentiation that provides sites for tissue-specific organization of
DNA sequences and regulates region-specific histone modifications
(Yasui et al., 2002; Cai et al., 2003). The closest homologue of Satb1,
Satb2, has recently been identified as a gene mutated in human patients
with cleft palate (FitzPatrick et al., 2003). It has also been demonstrated
that SATB2 can enhance gene expression and that the protein can be
modified by sumoylation (Dobreva et al., 2003).
In this study we characterized the expression of both Satb1 and
Satb2 in the developing mouse CNS. Satb2 expression is largely
confined to subsets of postmitotic cells in the developing CNS with the
highest expression in the developing cerebral cortex. Satb1 is also
expressed in several regions of developing CNS, but their expression
patterns do not overlap during development. We have also demon-
strated that developing neocortex, but not basal ganglia, contains a
nuclear protein complex that can bind nuclear MARs. Satb2 protein is
a part of the complex. Our findings suggest that Satb2 and Satb1
represent a novel class of transcription regulators that control neuronal
differentiation of distinct neuronal subtypes by targeting chromatin
and regulating expression of multiple loci in a manner similar to Satb1
action within the T-cell lineage.
Materials and methods
MAR DNA labelling
PCR labelling of MAR probes was performed as described by
Nikolaev et al. (1996). Probes for binding with nuclear extract were
prepared as follows: MAR-containing fragments were PCR-amplified
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in a 50-lL reaction volume using the corresponding plasmid as
template and a library primer 5¢-ACTGAGCTCGAGTATCCATGA
ACA.
The PCR labelling was conducted in a final volume of 50 lL
containing 10 ng of the template fragment, 20 lm library primer
for MAR fragments, 200 lm each dCTP, dGTP and dTTP, 20 lm
dATP, 50 lCi [a-32P]dATP (Obninsk, Russia), 3 mm MgCl2,
10 mm Tris ⁄HCl (pH 8.3) and 50 mm KCl. The reaction was
proceeded as follows: 94 C for 0.8 min, 50 C for 0.6 min, 72 C
for 1 min, for 18 cycles. Reaction products were extracted with
phenol–chloroform, precipitated with ethanol and dissolved in TE
buffer (10 mm Tris ⁄HCl; 1 mm EDTA).
Animals
Wild-type and lbx1 knock-out mouse embryos were used to isolate
tissue samples. All animal manipulations were carried out in
accordance with German law and were approved by the Bezirksre-
gierung Braunschweig
Nuclear matrix preparation and in vitro binding of MARs
Animals were killed by cervical dislocation. Cortical hemispheres and
basal ganglia of embryonic day (E)18.5 embryos were surgically
removed and used for nuclear extract isolation. Nuclear extracts were
prepared from embryonic tissue by a high-salt extraction method
(Cockerill & Garrard 1986). Binding of radioactively labelled MARs
to the nuclear extract in vitro was carried out as described by
Izaurralde et al. (1988).
Generation of antibodies against Satb2 protein
In order to produce antibody against Satb2 we generated two different
peptides based on predicted protein sequence:
1. C-SSPSSSRTPQAKTSTPTT (453–470 amino acids)
2. C-QQSQPTKESSPPREEA (585–600 amino acids).
These peptides were coupled to BSA (Sigma, St Louis, MO, USA) via
MBS (Pierce, Rockford, IL, USA). Coupled peptides were injected
into rabbits for immunization. The serum was purified using affinity
resin columns (Pierce) pretreated with peptides 1 or 2. Purified serum
was tested at different dilutions on cryosections in immunohisto-
chemistry experiments and on Western blots with protein isolated from
the cortical tissue. Both antibodies (Ab1 and Ab2) gave positive
signals with cortical protein extract on Western blots (see Fig. 2).
Western blot analysis of the protein extracts from bacterial cells
expressing Satb2 cDNA also produced a band of the expected size
(data not shown).
RT-PCR amplification of Satb2 cDNA fragment
The cDNA fragment of the predicted protein KIA1034 (Satb2) was
amplified with following primers:
Fig. 1. Comparison of protein sequences for mouse Satb1 and Satb2. The numbers refer to the positions of amino acids. The black and open boxes denote the
conserved ‘Cut’ and ‘homeo’- domains. The dashes indicate identical amino acids. Dots indicate parts of one protein that do not have analogous amino acids in the
other protein.
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Satb2-dir 5¢-TTATTGTCAGAGATACTGCGT (exon 7)
Satb2-rev 5¢-TTCTGTTGGAGGAGGCGGTG (exon 10)
The cortical cDNA from E15.5 mice was used as a template. The PCR
product was cloned into the pGEM-T cloning system (Promega,





Embryos were sectioned at 7–10 lm with a cryostat (Leica), air dried
for 20 min, washed in PBS and fixed for 5 min in 4% paraformal-
dehyde (PFA) ⁄ PBS. After three washes in PBS, sections were
preblocked in 1% BSA ⁄ 0.1% Tween 20 ⁄ PBS (1 h), and incubated
with primary antibodies overnight at 4 C in the same solution.
Sections were then washed in PBS and incubated with a diluted
(1 : 1000) goat anti-rabbit secondary antibody (Molecular Probes) for
1 h at room temperature, rinsed with PBS and visualized under a
fluorescence microscope. The working dilutions of the Satb2
antibodies were 1 : 100 for immunohistochemistry and 1 : 1000 for
Western blotting.
The following antibodies were used: guinea-pig anti-Lbx1 (kindly
provided by Dr C. Birchmayer), mAb Isl1 ⁄ 2 and Lim1 ⁄ 2 (4F2)
(Developmental Studies Hybridoma Bank, University of Iowa, USA),
guinea-pig anti-Lmx1b (kindly provided by Dr T. Jessell) and rabbit
anti-Tbr1 (kindly provided Dr M. Sheng).
For BrdU birth-dating experiments, BrdU (100 mg ⁄ g body weight)
(Sigma) ⁄ PBS was injected intraperitoneally at E11.5. Incorporated
BrdU was detected with mouse anti-BrdU mAb (Sigma).
In situ hybridization
Radioactive in situ hybridization was performed as described by
Stoykova & Gruss (1994). As probes, coding and non-coding regions
Fig. 4. Comparative expression of Satb2 at E15.5 in the forebrain. (A, G, J and L) Dark field images; (B–F, H, I, K, M and O) bright-field images. (H and I)
Comparison of Satb2 expression (B) with that of Svet1 (C), Pax6 (D), Dlx1 (E) and Satb1 (F). G–I and J–L are high-magnification views of the boxed regions
from A–C. The dashed lines in G, H and I demarcate the limits of the SVZ. The dashed lines in J and L demarcate the limits of Satb2 and Satb1 expression in the
piriform cortex. (O) Satb2 mRNA distribution in the adult brain. Abbreviations: BG, basal ganglia; cp, cortical plate; iz, intermediate zone; SVZ, subventricular
zone; pcx, piriform cortex; VZ, ventricular zone.
Fig. 3. Satb2 and Satb1 mRNA distribution in the developing mouse embryo at E13.5. (A, B, D and F) Dark-field images; (C and E) bright-field images. At E13.5
Satb2 and Satb1 are expressed in a mutually exclusive manner (A and B). Satb2 is mostly expressed in the neocortex and in the maxilla and mandible (B and D) and
in the spinal cord (F; for spinal cord expression see Results). Satb1 is largely expressed in the spinal cord, in the transition field between medulla and pons and in
two groups of cells in the ventral telencephalon (A). Main sites of expression are depicted by arrowheads. Abbreviations: BG, basal ganglia; m, medulla; mx,
maxillar component; nc, nasal capsule; nt, notochord; p, pons; tn, tongue
Fig. 2. Western blots with Ab1 and Ab2 anti-Satb2 antibodies. Lanes 1 and 5
contain total proteins and 2 and 6 nuclear extracts isolated from the E18.5
neocortex. Lanes 3 and 4 and 7 and 8 contain nuclear extracts isolated from the
HeLa cells and E18.5 basal ganglia, respectively. Note that for each antibody
there is a band of size close to the predicted size of 95 kDa and an additional
smaller band. The smaller bands, however, are not present in the nuclear
extracts (lanes 2 and 6).
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were used. The coding region was amplified with primers Satb2-dir
and Satb2-rev (see above).
Results
Identification and structural characterization of a novel
Satb1-related homeobox gene
In order to identify genes involved in the control of mouse neocortical
differentiation we performed a subtractive hybridization of mouse
E15.5 PCR-amplified neocortical cDNA against that of E13.5
(Rebrikov et al., 2000). From this cDNA subtraction we selected
several genes that were up-regulated in the neocortical subventricular
zone (SVZ) at E15.5. A novel cDNA of 1.7 kb (clone A11) showed
strong expression in the upper part of the cortical SVZ at E15.5 stage
(see below).
In order to isolate a full cDNA copy of the corresponding gene we
applied a modified 5¢-RACE technology (Matz et al., 1999) that
allowed us to isolate 9.6 kb of the A11 clone upstream region. This
region did not contain any significant open reading frame, indicating
that the cloned part of the gene belonged to either the 3¢ ⁄ 5¢
untranslated region (UTR) or was an intronic part of the underspliced
RNA captured in the process of cDNA preparation. The latter
hypothesis was confirmed after analysis of the Celera database. The
isolated 9.6-kb sequence showed 100% homology to an intronic part
of a gene KIA1034 identified in the Kazusa cDNA sequencing project
(Kikuno et al., 2000). In order to confirm the expression pattern of
KIA1034, we amplified a 538-bp part of a coding region from exons
7–10 of KIA1034 by PCR from the mouse E15.5 neocortical cDNA.
This cloned fragment was used as a probe for in situ hybridization on
paraffin sections. It produced an expression pattern identical to that of
clone A11, indicating that A11 was a cDNA product of underspliced
KIA1034 mRNA.
The KIA1034-predicted cDNA encoded a 733-amino-acid protein
of 85.5 kDa. A GenBank protein homology search revealed that the
Satb1 homeobox-containing gene was its closest homologue. We
referred to the gene therefore as Satb2. Alignment of the Satb1 and
Satb2 amino acid sequences showed an identity of 61% and similarity
of 73% (Fig. 1). Both proteins have two ‘cut’ domains and an atypical
homeodomain. A search of the GenBank database did not reveal
anything other than Satb1 homologues, indicating that Satb1 and
Satb2 are the only members of Satb subfamily of cut domain
homeobox genes in the mammalian genome.
Satb2 antibody production and specificity verification
In order to extend the analysis of the Satb2 protein two antisera were
raised in rabbits. The first, Ab1, was directed towards the peptide
localized between amino acids 453 and 470 of the protein and the
other, Ab2, was directed towards the peptide localized at positions
585–600 (Fig. 1, see also Materials and methods). Both peptide
sequences were selected in the regions of the protein that did not show
any homology to Satb1 and were unique for Satb2. In order to test
these two antisera, Satb2 recombinant protein was produced in
Escherichia coli. Western blots probed with Ab1 or Ab2 strongly
revealed the protein (data not shown). Both antibodies were then
tested for specificity by Western blotting on homogenates of
embryonic neocortex, basal ganglia and HeLa cells (Fig. 2). Two
protein bands were recognized by both antibodies. The heavier bands,
with an apparent molecular weight of approximately 95 kDa, were
identical for both antibodies (the predicted molecular weight of the
Satb2 protein is 85.5 kDa). Two other bands had a size of 30 kDa for
Ab1 and 50 kDa for Ab1. These bands did not appear in the cortical
nuclear extracts, indicating that the corresponding cross-reacting
antigens were present in the cytoplasm but not in the nucleus (Fig. 2).
We also performed immunohistochemical experiments on frozen
and paraffin sections of embryos or brains taken from different stages
of gestation. Both antibodies produced nuclear staining typical for a
transcription factor (see below). The signal was always detected in the
tissues where Satb2 RNA was detected too (see description of Satb2
protein expression below).
All these results indicate that both antibodies specifically recognize
Satb2 in the nuclear extracts and nuclei in the tissue.
Developmental distribution of Satb2 mRNA and protein
suggests a role in neuronal differentiation
The tissue distribution of Satb2 RNA and protein was analysed by
radioactive in situ hybridization and immunohistochemistry (Figs 3–
6). We also compared Satb2 expression with that of Satb1 and several
other molecular markers. The first site of Satb2 expression was
detected at E11.5 within the mandibular and maxillar components of
the first developing brachial arch (Fig. 5A and B). At E13.5 Satb2
mRNAwas additionally detected in the telencephalon, tongue muscles
and in a subpopulation of dorsal spinal cord neurons (Fig. 3B, D and
F). Satb1 expression at E13.5 was broader than that of Satb2. In
contrast to Satb2, Satb1 mRNAwas detected in the whole spinal cord
and in two groups of postmitotic cells of the ventral telencephalon
(Fig. 3A). Interestingly, Satb1 was strongly expressed in the region of
the pons ⁄medulla transition (Fig. 3A). Satb1 signal in the cerebral
cortex at E13.5 was mostly confined to the SVZ zone of differentiating
cells (Fig. 3B).
At E15.5, within the cortex and SVZ, Satb2-positive cells were
detected in the intermediate zone (IZ) and cortical plate (CP) (Fig. 4B
and H). Satb1 expression at E15.5 within the telencephalon was
detected in the cells of the marginal zone (MZ) and subplate cells of
the developing hippocampus (Fig. 4B and H). Satb1 was also detected
in the piriform cortex and olfactory tubercle (Fig. 4F). Interestingly,
medial boundary of Satb1 expression in the piriform cortex coincided
with the lateral boundary of Satb2 expression in the neocortex
Fig. 5. Satb2 protein distribution and birth dating of Satb2-expressing neurons. (A) Saggital and (B) transverse sections of E11.5 mouse embryos. Satb2 protein
is expressed in the cells of lateral nasal process and developing jaws. (E) Satb2 protein distribution in the E13.5 diencephalon. Three groups of Satb2 cells are
depicted by arrowheads. (G) Satb2 protein in the E15.5 telencephalon. Satb2 expression in neocortex (C) and spinal cord (D) 24 h after a BrdU pulse. Double-
labelled cells are absent from both the telencephalon and the spinal cord. Abbreviations: Aa, amygdala; cp, cortical plate; Hth, hypothalamus; iz, intermediate zone;
ln, lateral nasal process; lv, lateral ventricle; ms, mandibular swelling; pcx, piriform cortex; sp, spinal cord; Th, thalamus.
Fig. 6. Colocalization of Satb2 protein with Tbr1, reelin and calbindin in the neocortex. IHC with polyclonal anti-Satb2 (A) and anti-Tbr1 (B) antibody at E15.5.
C and D are high-magnification views of the boxed regions shown in A and B. Double IHC with polyclonal anti-Satb2 and monoclonal anti-reelin (E) and anti-
calbindin (F) antibodies at P0.
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(Fig. 4J–M). This boundary also coincided with the anatomical
boundary between the neocortex and piriform cortex (Fig. 4J and L).
By contrast, the medial boundary of Satb2 expression coincided with
the anatomical boundary between the subiculum and hippocampus
(Fig. 4A and B). Expression patterns of Satb2 and Satb1 did not
overlap in the telencephalon, indicating that they do not have a
redundant function in this tissue.
In order to attribute Satb2 expression to certain subpopulations of
the developing telencephalon we compared its expression with the
expression of other molecular markers. These markers included reelin
as a marker of Cajal-Retzius cells, calbindin as a marker of some
GABAergic cells, Dlx1 as a marker of basal ganglia born interneurons
(Anderson et al., 1997), Tbr1 as a marker of neocortical deep layers
(Hevner et al., 2001), Pax6 as a marker of the pallial ventricular zone
(VZ) and Svet1 as a marker of the SVZ. Expression of Satb2 neither
overlapped with the expression of Pax6 nor overlapped with the
expression of Dlx1 (Fig. 4B, D and E). While Pax6 signal in the
pallium was largely confined to the VZ, Satb2 signal was detected in
the SVZ, IZ and CP. Expression of Satb2 in the neocortical SVZ
partially overlapped with the expression of Svet1. Svet1 expression
labels the whole SVZ at E13–E15 (Tarabykin et al., 2001). In contrast,
Satb2 mRNA within the SVZ was detected largely in its upper parts
(Fig. 4J–I). Comparing their expression at latter stages we observed
that while Svet-positive cells stay in the SVZ until E17.5 (Tarabykin
et al., 2001), a significant portion of Satb2-positive cells begin
migration towards the cortical plate as early as E14.5 (data not shown).
At E15.5 many Satb2-positive cells have already reached the CP
(Fig. 4B and H). By E18.5 the majority of Satb2-positive cells occupy
the upper part of the CP (data not shown).
Double immunohistochemistry (ICH) with anti-Satb2 and anti-
reelin antibodies at E15.5 and postnatal day (P)0 did not reveal any
double positive cells (Fig. 6E). Reelin-positive cells were located in
the MZ, which was free from Satb2-positive cells. Most of the
calbindin-positive cells did not express Satb2 either (Fig. 6F),
although we did detect a few cells weakly labelled by both calbindin
and Satb2 (data not shown). We also compared the expression of
Satb2 and Tbr1 proteins on adjacent sections at E15.5. Most of the
Satb2-positive cells were detected in the upper part of the CP whereas
Tbr1-positive cells occupied the deeper part of the CP (Fig. 6A–D).
These data indicate that most of the Satb2-positive cells do not
coexpress Tbr1, although it is possible that there is a minor portion of
Satb2 cells that could also express Tbr1.
ICH staining for Satb2 protein at E15.5 showed that roughly half of
the neurons of the CP contained Satb2 protein (Fig. 5F). Satb2 protein,
in contrast to mRNA, was not detected in the neocortical SVZ cells
(Fig. 5F). These results suggest either a postranscriptional regulation of
Satb2 expression or a lower sensitivity of ICH detection as compared
with in situ hybridization. Such a difference was not detected for other
parts of the CNS expressing Satb2. In the developing diencephalon
there were three groups of Satb2-positive cells: ventrally, medially and
dorsally (Fig. 5E). In the adult brain Satb2 was expressed in the
neocortex and hippocampus although its expression is decreased as
compared with that in the embryonic brain (Fig. 4O).
Birth-timing of Satb2-positive neurons in the telencephalon
and spinal cord
In order to determine the birth-time of Satb2-positive neurons we
injected pregnant females with BrdU at E11.5. The embryos were
taken for IHC analysis 24 h later. Embryo sections were subjected
to double IHC with anti-BrdU and anti-Satb2 antibodies. We did
not detect any double positive cells in the neocortex or in the spinal
cord (Fig. 5C and D). Satb2-positive cells in the telencephalon were
located mostly in the lateral cortical plate directly above the layer
of BrdU-positive cells (Fig. 5C). A similar situation was observed
in the spinal cord – all the Satb2-positive cells were situated in the
MZ outside the domain of BrdU-positive cells in the VZ (Fig. 5D).
These results indicate that Satb2-positive cells in the spinal cord
and early born Satb2-positive cells in the telencephalon are
generated before E11.5.
Satb2 expression in the dorsal spinal cord identifies a subgroup
of Lbx1-positive neurons and is abolished in lbx1 mutants
The first Satb2-expressing cells in the spinal cord were detected at
E12.5 and were observed at all axial levels of the spinal cord. Three
domains of Satb2 expression – dorsal, medial and ventral – can be
distinguished at this stage within the spinal cord (Fig. 7E). In order to
attribute Satb2 to certain neuronal classes we performed double
immunostaining of Satb2 and other spinal cord neuronal markers.
Staining with anti-Isl1 ⁄ 2 antibody demonstrated that all ventral Satb2
neurons were also coexpressing Isl1 ⁄ 2. However, not all Isl1 ⁄ 2
ventral neurons were Satb2 positive (Fig. 7C and E). Satb2-positive
neurons in the dorsal portion of the spinal cord were not positive for
either Isl1 ⁄ 2, Lmx1b (Fig. 7) or Evx1 (data not shown). They were,
however, positive for both Lim1 ⁄ 2 and Lbx1 proteins (Fig. 7).
Notably, Satb2-positive cells were expressing Lbx1 at a lower level
than most of the other Lbx1 neurons (Fig. 7G–I). Satb2-positive dorsal
neurons were located at the lower boundary of dorsal Lbx1 expression
(Fig. 7). Interestingly, a subset of Satb2-positive cells located at this
stage in the upper portion of the ventral spinal cord do not coexpress
any molecular marker tested.
In order to study whether Satb2 is situated downstream of Lbx1
transcription factor we studied the expression pattern of Satb2 in the
spinal cord of lbx1– ⁄ – mutant E12.5 embryos. The amount of Satb2-
positive cells was significantly decreased in the dorsal part of the
spinal cord in the mutants. At the same time, ventral and medial Satb2
expression domains appeared to remain unchanged (Fig. 8).
Satb2 in the cerebral cortex is a part of a nuclear complex
interacting with nuclear MARs
In order to investigate the ability of Satb2 protein to bind MARs, we
first selected those MARs that can interact with nuclear extracts from
the tissue with the highest concentration of Satb2 protein. Developing
E18.5 cerebral cortex was selected as a tissue source on the basis of
expression experiments. Figure 9 shows an autoradiogram of gel
Fig. 7. Satb2 expression demarcates a subset of Lbx1-positive neurons in the spinal cord. Colocalization of Satb2 protein with Lbx1 (A, F), Isl1 ⁄ 2 (C, E), Lim1 ⁄ 2
(B) and Lmx1b (D) in the E12.5 and E13.5 spinal cord. (G–I) High-magnification views of F. (H) Superimposition of G and I. Satb2 protein in the dorsal spinal cord
is coexpressed with Lbx1 and Lim1 ⁄ 2 but not with Lmx1b and Isl1 ⁄ 2. Arrowheads on G, H and I depict a typical Lbx1+ ⁄ Satb2+ neuron. Level of Lbx1 expression
is lower than in a neighbouring Lbx1+ ⁄ Satb2– neuron. (J) Schema of updated classification of dorsal spinal cord neurons including Satb2 as a possible marker of dI6
neurons.
Fig. 8. Satb2 expression is decreased in the spinal cord of lbx1– ⁄ – mutant. Colocalization of Satb2 (C) and Isl1 ⁄ 2 (A) in the E12.5 spinal cords of lbx1– ⁄ – mutant.
(B) Superimposition of A and C. Note the remaining group of Satb2-expressing cells in the ventral part of the spinal cord on C. (D) Satb2 expression in the spinal
cord of E12.5 lbx1– ⁄ – mutant and a wild-type littermate (E). Arrowhead in D indicates the region corresponding to the region of dorsal Satb2 cells in the wild type.
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mobility shift experiments carried out with hamster and human MARs.
The MARs taken for the analysis have been shown to attach to the
nuclear scaffold (Nikolaev et al., 1996). In six of ten MAR sequences
tested, the addition of nuclear extracts from the cortical tissue resulted
in the appearance of a shifted band (Fig. 9A). The shifted bands
showed an appearance of a single major binding complex. Interest-
ingly, nuclear extracts isolated from E18.5 basal ganglia tissue for all
but MAR148 did not produce strong shifted bands (Fig. 9C). In the
case of MAR148 (M2E4) a weaker band of similar size to that of
cortical band. Formation of the shifted complex was inhibited by
specific unlabelled competitor DNA (Fig. 9B).
We then tested whether Satb2 is a part of the MAR-binding
complex in the cerebral cortex. The presence of Satb2 protein in the
cortical nuclear extracts was confirmed on a Western blot (Fig. 2)
using Ab1 and Ab2 antibodies. In order to detect Satb2 within
the cortical MAR binding complex, Ab1 antibody was added to the
binding reaction. For all three MARs tested this resulted in the
supershift of the DNA–protein complex (Fig. 9A). In the negative
control experiments the antibody was added to the nuclear extract
isolated from HeLa cells, where Satb2 protein was not detected. These
experiments, as expected, did not produce any band supershift.
Discussion
Satb2 expression delineates subsets of differentiating neurons
in the developing CNS
The problem of characterization of different cell types is a common
one in many regions of the CNS. The molecular profile of a certain
cell type is an important aspect of neuronal phenotype. In this study
we investigated Satb2 mRNA and protein distribution with embryonic
development. Most of the cells expressing the gene were found within
the CNS and developing cartilage tissue. In all regions of the CNS,
Satb2 expression peaked in differentiating neurons and decreased in
Fig. 9. Interaction of Satb2 containing protein complex with MAR DNA. (A) Gel mobility shift assay with three different radiolabelled MARs. Lanes 1, 7 and 13
contain samples with no protein. Lanes 2, 8 and 14 contain MARs that were reacted with mouse cortical nuclear extracts. Lanes 3, 9 and 15 were loaded with the
binding reaction, additionally containing anti-Satb2 antibody Ab1. Lanes 4, 10 and 16 contain the binding reaction containing Ab2 antibody. Lanes 6, 12 and 18 and
5, 11 and 17 contain negative control samples with nuclear extracts isolated from the HeLa cell line that were reacted with MARs with (lanes 6, 12, 18) or without
(lanes 5, 11, 17) Ab1 antibody. ‘Band shift’ and ‘superband shift’ are depicted with arrowheads. (B) Competition assay. Lanes 3–5 and 8–10 contain increasing
amounts (10, 50 and 200 ng) of specific unlabelled competitor DNA. Lanes 1 and 6 do not contain any protein; lanes 2 and 7 do not contain the competitor DNA.
(C) Nuclear extracts from the E18.5 mouse neocortex have stronger MAR binding activity than those from the E18.5 basal ganglia. Lanes 1, 4 and 7 do not contain
any protein; lanes 2, 5 and 8 contain samples with nuclear extracts isolated from the neocortex; lanes 3, 6 and 9 contain samples with nuclear extracts isolated from
the basal ganglia. Note that all three MARs showed formation of a strong single shifted band in for the neocortex, but only in one case was there formation of a much
weaker band for the basal ganglia (arrowhead).
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mature cells. This suggests that Satb2 is involved in the control of
neuronal differentiation. The highest proportion of Satb2-expressing
neurons, greater than 50%, was detected in the neocortex between
E15.5 and E18.5. In the other parts of the CNS where Satb2 was
expressed, such as spinal cord and thalamus, Satb2-positive cells were
minor subpopulations comprising not more than 5–10% of all cells.
Interestingly, in the neocortex, Satb2 protein, in contrast to mRNA,
was not detected in the SVZ but was detected in the CP. Although
this finding could be a result of low sensitivity of IHC, it may also
be explained by a Satb2 translation block in the neocortical SVZ
cells.
Novel molecular classification of cortical neurons has been
suggested recently by Hevner et al. (2003). Cortical neurons were
classified on the basis of gene expression profiles. Our data
corroborate Satb2 as a valuable marker of cortical superficial layers.
Satb2-positive cells do not express reelin, and most do not express
Tbr1 and calbindin. Our data also indicate that Satb2 is not expressed
in the cells that express another marker of superficial layers and the
SVZ, Svet1. However, there may be minor subgroups of cells
coexpressing Satb2 and Svet1, or Satb2 and Tbr1. Further experiments
will need to be performed to address this issue.
Recently, a new classification of dorsal spinal cord neurons was
suggested (Gross et al., 2002; Muller et al., 2002). According to the
new classification early dorsal neurons consist of two major classes,
Lbx1-negative (class A) neurons and Lbx1-positive (class B) neurons.
The latter are subdivided into three classes: D3 (dI4), D4 (dI5) and D5
(dI6). These neurons are distinguished on a basis of the expression of
certain combinations of transcription factors that control their
differentiation. Two of these groups, however, D3 (dI4) and D5
(dI6), have been undistinguishable by means of molecular markers.
Both D3 (dI4) and D5 (dI6) neurons coexpress Lbx1 and Lim1 ⁄ 2.
Thus far, they have been distinguished only by their positions along
the dorso-ventral axis (Gross et al., 2002; Muller et al., 2002). Our
colocalization experiments demonstrated that dorsal Satb2-expressing
cells also express Lbx1 and Lim1 ⁄ 2 but do not express Lmx1b or Isl1.
The fact that dorsal Satb2 neurons are located in the most ventral part
of the Lbx1 expression domain suggests that Satb2-expressing cells
could be either dI4 or dI6 neurons. This is also supported by the fact
that Satb2-positive neurons in the spinal cord appear before E11.5.
Additionally, we have detected a decrease of Satb2-expressing cells
in the dorsal part of the spinal cord of lbx1– ⁄ – mutants. It has been
shown that inactivation of the Lbx1 gene in the spinal cord leads to
ablation of class B neurons (Gross et al., 2002; Muller et al., 2002). It
is not clear whether Satb2 is a direct target of Lbx1, or whether the
lack of Satb2-positive cells in the dorsal part of the spinal cord is the
result of re-specification of these cells.
Satb2 and Satb1 as potential chromatin remodelling regulators
in the developing CNS
Using the cDNA subtraction approach we isolated and characterized a
novel mouse gene Satb2 that encodes a Satb1 homologous transcrip-
tion factor. We demonstrate that endogenous Satb2 protein is a part of
a protein complex that binds to the MARs. It has been demonstrated
that Satb1 also binds to MARs and regulates expression of multiple
genes in the maturating T-cells. It is suggested that Satb1 acts as a
global regulator of thymocyte differentiation that provides sites for
tissue-specific organization of DNA sequences and regulates region-
specific histone modifications. It has been reported that Satb1 is
expressed predominantly in thymocytes (Dickinson et al., 1992;
Adams et al., 1993) but was also detected in the fetal brain (Adams
et al., 1993). We demonstrate here that during development Satb1 is
expressed in several regions of the developing CNS. Satb2 is also
expressed in the developing CNS, but expression patterns of Satb2 and
Satb1 do not overlap. In the developing cerebral cortex, for example,
Satb1 is expressed in the MZ and piriform cortex whereas Satb2 is not
expressed in these cells. Satb2, in turn, is largely expressed in the
superficial layers of the neocortex and subiculum. It has been reported
that Satb1 knock-out mice have a neurological phenotype such as
incomplete eye opening and the clasping reflex (Alvarez et al., 2000).
Our results, together with the previous reports, suggest that Satb2 and
Satb1 can act as global regulators of cell differentiation in specific cell
lineageas within the developing CNS. The molecular basis for Satb1
action was recently demonstrated by Kohwi-Shigematsu and coau-
thors (Yasui et al., 2002; Cai et al., 2003). They have shown that Satb1
forms a three-dimensional network structure in the thymocyte nuclei
and recruits the histone deacetylase into this network. Their results
convincingly demonstrate that Satb1 defines a novel class of
transcription regulators that function as a protein defining the sites
within a chromosome that should be subjected to chromatin remod-
elling. Satb2 has been recently identified as a gene mutated in human
patients with cleft palate. It has also been demonstrated that Satb2 can
enhance gene expression and the protein can be modified by
sumoylation (FitzPatrick et al., 2003; Dobreva et al., 2004).
The mutually exclusive expression of Satb2 and Satb1 suggest that
they control the expression of distinct subsets of genes at the level of
chromatin in the developing CNS. Within the CNS there are still cells
that do not express either Satb1 or Satb2. Because we did not identify
anything other than Satb1 homologues of Satb2 in the mouse genome,
it is likely that there should be other proteins similar to Satb1 and
Satb2 functioning in other neural cells. It remains to be elucidated
whether Satb1 and Satb2 can be substituted for one another or whether
each has a unique set of targets. Further experiments involving
‘knock-in’ experiments need to be performed in order to address this
question.
For band-shift analysis we randomly selected ten MARs from the
human and hamster genome. Six of these MARs strongly interact with
a nuclear protein complex isolated from developing neocortex. We
have also demonstrated that endogenous Satb2 protein is a part of the
MAR-interacting complex. Note that none of the MARs demonstrated
strong interaction with basal ganglia nuclear proteins isolated from the
same stage. This surprising finding suggests that the level of chromatin
remodelling reactions at E18.5 is higher in the neocortex than in the
basal ganglia. It can be explained by the fact that the basal ganglia
tissue, although most closely related to the neocortex, is more
developmentally advanced at E18.5 and that most of the chromatin
remodelling processes could be completed by E18.5. Another possible
explanation is that the neocortex, having a higher cellular diversity in
general, requires a higher level of chromatin remodelling. The latter
hypothesis is also supported by the fact that a histone acetyltransferase
gene Querkopf is strongly expressed in the neocortex and is required
for normal cerebral cortex development (Thomas et al., 2000).
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